1. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Issue 10088 (24th June 2017) Authors: Gupta, Ajay; Thompson, David; Whitehouse, Andrew; Collier, Tim; Dahlof, Bjorn; Poulter, Neil; Collins, Rory; Sever, Peter Journal: Lancet Issue: Volume 389:Issue 10088(2017) Page Start: 2473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗